LIEBERMAN GERALD M — SEC Form 4 filings
SEC reporting owner CIK 1234346. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-10 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Director | 5 | — | — | 9 |
| Entera Bio Ltd. (ENTX) | Director | 5 | — | — | 8 |
Form 4 filings — LIEBERMAN GERALD M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 14,492 · Option exercise (M): 14,492 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 7,242 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Entera Bio Ltd. (ENTX) | Grant/award (A): 38,294 @ $0 · Grant/award (A): 33,505 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 9,632 · Option exercise (M): 9,632 (derivative) @ $0 · Grant/award (A): 14,492 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Entera Bio Ltd. (ENTX) | Option exercise (M): 23,952 @ $1 · Option exercise (M): 23,952 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Entera Bio Ltd. (ENTX) | Grant/award (A): 10,717 @ $0 · Grant/award (A): 28,509 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Entera Bio Ltd. (ENTX) | Grant/award (A): 11,269 @ $0 | EDGAR |
| 2024-08-29 | 4 | Entera Bio Ltd. (ENTX) | Grant/award (A): 27,261 @ $0 | EDGAR |
| 2024-06-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 21,108 · Option exercise (M): 21,108 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 9,632 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1234346 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →